
About Dupen Laboratories Private Limited
Data last updated:
Dupen Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 1976 and has been in existence for over 50 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1976PTC103955. Its GSTIN is 27AAACD2943E1ZZ (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹9.86 Lakh. It was formerly known as Rama Pharma Lab Pvt Ltd and Rama Laboratories Pvt Ltd. It is led by directors including Rajeshwari Datla (Managing Director) and Nagendra Varaprasad Nadimpally (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.2 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹63.72 Lakh (net margin -7.8%) and EBITDA of -₹49.39 Lakh (EBITDA margin -6%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 13% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Dupen Laboratories. As per MCA filings, the company has satisfied charges of ₹3.19 Cr on record. Court records list 30 cases involving the company, including 8 filed by the company and 22 filed against it; 18 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dupenlabs.com.
Company details
Name history
Dupen Laboratories has undergone 2 name changes throughout its history. The company was previously known as Rama Pharma Lab Pvt Ltd, and Rama Laboratories Pvt Ltd. The current legal name is Dupen Laboratories Private Limited.
| Company Name | Status |
|---|---|
| Dupen Laboratories Private Limited | Current |
| Rama Pharma Lab Pvt Ltd | Previous |
| Rama Laboratories Pvt Ltd | Previous |
CIN history
Dupen Laboratories has one previous CIN (Corporate Identification Number): U24239MH1996PTC103955. The current CIN is U24239MH1976PTC103955, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH1976PTC103955 | Current |
| U24239MH1996PTC103955 | Previous |
Contact details
Dupen Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is dupenlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDheeraj Heritage 18 5th Floor, S. V. Road Near Best Depot, Mumbai, Maharashtra, India – 400054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dupen Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Dupen Laboratories operates one associated brand: Dupen Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets its own pharmaceutical brands while providing CMO services. | dupenlabs.com |
Business activity
The main business activity of Dupen Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dupen Laboratories Private Limited, buy the company report.
Financials of Dupen Laboratories Private Limited
FY 2025 filings availableDupen Laboratories Private Limited reported revenue of ₹8.2 Cr (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 35% fall in the latest year. EBITDA fell 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹49.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹63.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6% | ||||
| Net Profit Margin | -7.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dupen Laboratories Private Limited, buy the company report.
Board of directors of Dupen Laboratories Private Limited
Dupen Laboratories has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeshwari Datla Also directs: Fermenta Biotech Limited, Lacto-Cosmetics (Vapi) Private Limited | Managing Director | 01 Jan 1995 | 31 Years 10 Months | Current |
| Nagendra Varaprasad Nadimpally Also directs: Lacto-Cosmetics (Vapi) Private Limited | Whole-Time Director | 01 Jan 2017 | 9 Years 10 Months | Current |
| Anupama Datla Desai Also directs: Fermenta Biotech Limited, Lacto-Cosmetics (Vapi) Private Limited | Director | 15 Dec 2004 | 21 Years 10 Months | Current |
Peer comparison
Dupen Laboratories Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mars Pharma Private Limited | ₹8.22 Cr (FY 2024) | 39.0% | Hyderabad, Telangana, India | |||
| Dupen Laboratories Private Limitedthis company | ₹8.2 Cr (FY 2025) | -₹63.72 Lakh | -7.8% | -35.0% | 6 | Mumbai, Maharashtra, India |
| KFS Biotech Private Limited | ₹8.15 Cr (FY 2025) | 9.0% | Baddi, Himachal Pradesh, India | |||
| Gujarat Mitul Petro -Pharma Private Limited | ₹8.15 Cr (FY 2024) | -19.0% | Vadodara, Gujarat, India | |||
| KST Pharmaceuticals Private Limited | ₹8.12 Cr (FY 2024) | 552.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Dupen Laboratories Private Limited, buy the company report.
Auditor
Dupen Laboratories Private Limited is audited by M M Nissim & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M M Nissim & Co. | FY 2023 | 107122W |
Shareholding
The shareholding of Dupen Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dupen Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2009 | 10193459 | Corporation Bank | ₹2.55 Cr | Satisfied | |
| 05 Nov 1993 | 90347524 | Bank of Baroda | ₹37 Lakh | Satisfied | |
| 28 Mar 1992 | 90348065 | Bank of Baroda | ₹9 Lakh | Satisfied | |
| 19 Jul 1990 | 90348011 | Bank of Baroda | ₹10.2 Lakh | Satisfied | |
| 30 Jan 1986 | 90346185 | Bank of Baroda | ₹2 Lakh | Satisfied |
To see the full charge records of Dupen Laboratories Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Dupen Laboratories Private Limited has 30 court cases on record: 8 filed by Dupen Laboratories, 22 filed against it. 18 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 26 | 19 | 18 |
| High courts | 3 | 2 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 30)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Necs Pharma LLP and 2 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against Necs Pharma LLP and 2 others | Pending |
| District court, Durg, Chhattisgarh | Civil suit | Filed against the company by an individual | Pending |
| District court, Valsad, Gujarat | Court case (REFER T LC) | Filed against the company by an individual | Pending |
| District court, Valsad, Gujarat | Court case (REFER T LC) | Filed against the company by an individual | Pending |
To see the full case history of Dupen Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dupen Laboratories Private Limited has 3 MSME Form 1 returns on record between 2019 and 2024, listing 27 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Dupen Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dupen Laboratories Private Limited has a workforce of 6 employees on its EPFO records as of Aug 26, 2024, across 1 active EPFO establishment.
GST
Dupen Laboratories has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACD2943E1ZZ | Maharashtra | Active | 01 Jul 2017 |
| 24AAACD2943E1Z5 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dupen Laboratories Private Limited, buy the company report.
Recent activity
Dupen Laboratories Private Limited has 5 board changes on record since 1995: 3 appointments and 2 cessations. The latest: Nagendra Varaprasad Nadimpally was appointed as Whole-Time Director on 01 Jan 2017.
15 earlier events are in the company report.
Frequently asked questions
Dupen Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 1976 (50+ years old) and is registered under CIN U24239MH1976PTC103955.
Dupen Laboratories has 3 current directors:
- Rajeshwari Datla - Managing Director
- Nagendra Varaprasad Nadimpally - Whole-Time Director
- Anupama Datla Desai - Director
The latest financial statements of Dupen Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dupen Laboratories is 27AAACD2943E1ZZ, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACD2943E1Z5 (Gujarat).
The CIN (Corporate Identification Number) of Dupen Laboratories is U24239MH1976PTC103955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dupen Laboratories has 30 court cases on record: 8 filed by the company and 22 filed against it. 18 are pending. Most are in the district courts.
Dupen Laboratories was incorporated on 23 March 1976, making it 50+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dupen Laboratories by revenue are Mars Pharma Private Limited, KFS Biotech Private Limited, Gujarat Mitul Petro -Pharma Private Limited, KST Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nagendra Varaprasad Nadimpally was appointed as Whole-Time Director on 01 Jan 2017. Preeti Thakkar ceased to be Director on 01 Jan 2017. Chandrashekar Rao ceased to be Director on 02 Apr 2016. Dupen Laboratories has 5 board changes on record in total.
Dupen Laboratories has 3 MSME Form 1 returns on record between 2019 and 2024, listing 27 overdue payments to 22 micro and small suppliers. The latest return was filed on 03 May 2024.
Dupen Laboratories can be reached through the website dupenlabs.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Dupen Laboratories is at Dheeraj Heritage 18 5th Floor, S. V. Road Near Best Depot, Mumbai, Maharashtra, India – 400054.

